- Motley Fool•2 hours ago
Here's why AbbVie, Celgene, and Gilead Sciences are three of the least expensive biotech stocks around.
- Business Wire•7 hours agoREVLIMID® (Lenalidomide) Approved by the European Commission as Monotherapy for the Maintenance Treatment of Patients with Newly Diagnosed Multiple Myeloma after Autologous Stem Cell Transplantation
Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation , today announced that the European Commission has approved REVLIMID® as monotherapy for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation .
- Business Wire•20 hours agoCelgene Announces Retirement of President and Chief Operating Officer, Jacqualyn Fouse, Ph.D. and Promotion of Scott Smith to President and Chief Operating Officer
Celgene Corporation today announced that President and Chief Operating Officer Jacqualyn Fouse, Ph.D., has decided to retire from Celgene effective June 30, 2017.
CELG : Summary for Celgene Corporation - Yahoo Finance
Celgene Corporation (CELG)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||117.47 x 100|
|Ask||117.50 x 200|
|Day's Range||117.28 - 119.31|
|52 Week Range||94.39 - 127.00|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||47.16|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|